What is Sutro Biopharma, Inc.'s Market Cap?

Sutro Biopharma, Inc.'s Market Cap is $304.3M, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s Price / Sales?

Sutro Biopharma, Inc.'s Price / Sales is 6.7×, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s Revenue (TTM)?

Sutro Biopharma, Inc.'s Revenue (TTM) is $45.7M, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s Net Income (TTM)?

Sutro Biopharma, Inc.'s Net Income (TTM) is -$180.6M, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s EBITDA?

Sutro Biopharma, Inc.'s EBITDA is -$140.0M, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s Diluted EPS (TTM)?

Sutro Biopharma, Inc.'s Diluted EPS (TTM) is -10.89, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s EBITDA Margin?

Sutro Biopharma, Inc.'s EBITDA Margin is -306.3%, based on as-reported figures from SEC (XBRL) filings.

Sutro Biopharma, Inc. (STRO) Financial Statements

Sutro Biopharma, Inc.

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001T94MP6

XNAS · usd

18.36▼ 0.75 (-3.90%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close19.10

Day's Range18.24 – 19.46

52-Week Range0.72 – 43.85

Volume145.6K

Avg Volume239.2K

Share Statistics

Shares Outstanding

Employees137

ExchangeXNAS

Listed2018-09-27

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Sutro Biopharma, Inc. (STRO)

What is Sutro Biopharma, Inc.'s Market Cap?: Sutro Biopharma, Inc.'s Market Cap is $304.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s Price / Sales?: Sutro Biopharma, Inc.'s Price / Sales is 6.7×, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s Revenue (TTM)?: Sutro Biopharma, Inc.'s Revenue (TTM) is $45.7M, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s Net Income (TTM)?: Sutro Biopharma, Inc.'s Net Income (TTM) is -$180.6M, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s EBITDA?: Sutro Biopharma, Inc.'s EBITDA is -$140.0M, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s Diluted EPS (TTM)?: Sutro Biopharma, Inc.'s Diluted EPS (TTM) is -10.89, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s EBITDA Margin?: Sutro Biopharma, Inc.'s EBITDA Margin is -306.3%, based on as-reported figures from SEC (XBRL) filings.